Literature DB >> 32428625

The therapeutic effects of craniotomy versus endoscopic-assisted trepanation drainage for isolated chronic subdural haematoma (ICSH): A single-centre long-term retrospective comparison study.

Jibo Zhang1, Jincao Chen2.   

Abstract

BACKGROUND: Isolated chronic subdural hematoma (ICSH), as a special rare species, has great controversy over its treatment. A retrospective analysis was performed to compare craniotomy with endoscopic-assisted trepanation drainage (EATD) of ICSH.
METHODS: The data of ICSH patients for craniotomy or EATD from January 2011 to April 2019 were retrospectively collected and analysed. Of 106 patients, 49 and 57 patients received craniotomy and EATD treatment respectively. Recurrence rate, morbidity and mortality rate were the main outcome. RESULT: There was no recurrence in both groups. The morbidity rate of the EATD group (2/57, 3.5%) was significantly lower than that of the craniotomy group (17/49, 34.7%, p = 0.0033). There was no death in the EATD group, but 3 cases died of operative produce in the craniotomy group. The average operation time of the craniotomy group (95.3min) was significantly longer than that of the EATD group (66.5min, P =  0.0032). Craniotomy group had more intraoperative blood loss (213.2ml) than EATD group (34.5ml, P = 0.0044). EATD patients had shorter hospital stay and recovered faster.
CONCLUSIONS: Compared with craniotomy, EATD is a more effective and safer method for the treatment of ICSH.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic subdural haematoma; Craniotomy; Endoscope; ICSH; Trepanation drainage

Year:  2020        PMID: 32428625     DOI: 10.1016/j.brainresbull.2020.04.014

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  1 in total

1.  Efficacy of Neuroendoscopic Treatment for Septated Chronic Subdural Hematoma.

Authors:  Jianhong Deng; Fangyu Wang; Haojie Wang; Mingpei Zhao; Guorong Chen; Huangcheng Shangguan; Lianghong Yu; Changzhen Jiang; Wenhua Fang; Peisen Yao; Dezhi Kang; Shufa Zheng
Journal:  Front Neurol       Date:  2022-01-11       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.